These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1433822)

  • 1. Dilated cardiomyopathy with special reference to humoral immunity.
    Fukuta S; Yoshinaga T; Yamakawa K; Kimura Y; Kusukawa R
    Jpn Circ J; 1992 Oct; 56(10):1073-80. PubMed ID: 1433822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of immunological mechanism in dilated cardiomyopathy.
    Yamakawa K; Fukuta S; Yoshinaga T; Umemoto S; Itagaki T; Kusukawa R
    Jpn Circ J; 1987 Jun; 51(6):665-75. PubMed ID: 3669276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy. Correlation with disease severity and cardiac autoantibodies.
    Limas CJ; Goldenberg IF; Limas C
    Circulation; 1995 Feb; 91(3):631-4. PubMed ID: 7828286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immunity in cardiomyopathy.
    Lowry PJ; Thompson RA; Littler WA
    Br Heart J; 1983 Oct; 50(4):390-4. PubMed ID: 6354229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance.
    Caforio AL; Mahon NJ; Tona F; McKenna WJ
    Eur J Heart Fail; 2002 Aug; 4(4):411-7. PubMed ID: 12167378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum levels of soluble interleukin-2 receptor, neopterin and beta-2-microglobulin in idiopathic dilated cardiomyopathy: relation to disease severity and autoimmune pathogenesis.
    Caforio AL; Goldman JH; Baig MK; Mahon NJ; Haven AJ; Souberbielle BE; Holt DW; Dalgleish AG; McKenna WJ
    Eur J Heart Fail; 2001 Mar; 3(2):155-63. PubMed ID: 11246052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy].
    Lauer B; Padberg K; Schultheiss HP; Strauer BE
    Z Kardiol; 1995 Apr; 84(4):301-10. PubMed ID: 7785303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
    Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac myosin autoantibodies and acute rejection after heart transplantation in patients with dilated cardiomyopathy.
    Warraich RS; Pomerance A; Stanley A; Banner NR; Dunn MJ; Yacoub MH
    Transplantation; 2000 Apr; 69(8):1609-17. PubMed ID: 10836370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: pro-inflammatory antibodies in DCM patients.
    Warraich RS; Dunn MJ; Yacoub MH
    Biochem Biophys Res Commun; 1999 Jun; 259(2):255-61. PubMed ID: 10362496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fc(gamma) receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy.
    Staudt A; Eichler P; Trimpert C; Felix SB; Greinacher A
    J Am Coll Cardiol; 2007 Apr; 49(16):1684-92. PubMed ID: 17448369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of pathological parameters of endomyocardial biopsy in clinical outcome of patients of dilated cardiomyopathy--II. Value of cardiac immune complexes and heart reactive antibodies.
    Dawson L; Talwar KK; Chopra P
    Indian Heart J; 1991; 43(6):421-5. PubMed ID: 1823888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoadsorption as treatment option in dilated cardiomyopathy.
    Felix SB; Staudt A
    Autoimmunity; 2008 Sep; 41(6):484-9. PubMed ID: 18781476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy.
    Limas CJ; Goldenberg IF; Limas C
    Circ Res; 1989 Jan; 64(1):97-103. PubMed ID: 2535798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Humoral and cellular immunity in perimyocarditis and congestive cardiomyopathy].
    Maisch B; Kochsiek K
    Kardiologiia; 1985 Jun; 25(6):95-102. PubMed ID: 2995721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Idiopathic dilated cardiomyopathy: a persistent viral infection or an organ-specific autoimmune disease? The trial of 2 major pathogenetic hypotheses].
    Caforio AL; Bonifacio E; Keeling PJ; Grazzini M; Schiaffino S; Bottazzo GF; McKenna WJ
    G Ital Cardiol; 1992 Jan; 22(1):63-72. PubMed ID: 1624070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy.
    Shmilovich H; Danon A; Binah O; Roth A; Chen G; Wexler D; Keren G; George J
    Int J Cardiol; 2007 Apr; 117(2):198-203. PubMed ID: 16887211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-heart autoantibodies in familial dilated cardiomyopathy.
    Caforio AL; Vinci A; Iliceto S
    Autoimmunity; 2008 Sep; 41(6):462-9. PubMed ID: 18781472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
    Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S
    Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease-associated protein chip.
    Horn S; Lueking A; Murphy D; Staudt A; Gutjahr C; Schulte K; König A; Landsberger M; Lehrach H; Felix SB; Cahill DJ
    Proteomics; 2006 Jan; 6(2):605-13. PubMed ID: 16419013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.